Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.
Also called NCT01521845
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 104 participants
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Registry
-
NCT01521845
-
- Other papers using this trial's data
- Protection from procedural myocardial injury by omega-3 polyunsaturated fatty acids (PUFAs): is related with lower levels of creatine kinase-MB (CK-MB) and troponin I?
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Iran
- Registry status
- Completed
Technical summary
Registry record NCT01521845. Randomized; single masking; primary purpose prevention. Start 2012-01 (registry gives no type); primary completion 2012-05 (actual). Results posted on 2012-07-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)
- Condition
- Coronary Arteriosclerosis
- Intervention (Drug)
- omega 3
- Lead sponsor
- Shahid Beheshti University of Medical Sciences
Record details
- Record id
cardio:ct-nct01521845- Content hash
21b939334a23d087cbd2893b16ec606230c1f3c11341ec70f85a7f012ee5b438